SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-20-003951
Filing Date
2020-03-23
Accepted
2020-03-23 17:18:46
Documents
7
Period of Report
2020-05-18

Document Format Files

Seq Description Document Type Size
1 PRE 14A sgmo-2020_proxyxprelim.htm PRE 14A 1533307
2 sgmocdagraphiccashinc01.jpg GRAPHIC 99051
3 sgmocdagraphicceo2019a02.jpg GRAPHIC 43356
4 sgmocdagraphicfactors.jpg GRAPHIC 56944
5 sgmocdagraphicprimarya01.jpg GRAPHIC 54098
6 sgmoproxycardp1.jpg GRAPHIC 196286
7 sgmoproxycardp2.jpg GRAPHIC 95535
  Complete submission text file 0001628280-20-003951.txt   2264492
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-30171 | Film No.: 20735700
SIC: 2836 Biological Products, (No Diagnostic Substances)